Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

UCB Ventures

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
The average size of a deal this fund participated in
Portfolio companies 10
Rounds per year 2.40
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 5
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science

UCB Ventures appeared to be the VC, which was created in 2017.

Besides them, we counted 5 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the UCB Ventures, startups are often financed by The Westly Group, HealthTech Capital, CVSHealth. The meaningful sponsors for the fund in investment in the same round are The Westly Group, Temasek Holdings, Qiming Venture Partners. In the next rounds fund is usually obtained by Muscular Dystrophy Association.

The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Locana, MyHealthTeams. Among the most successful fund investment fields, there are Social Network, Medical.

The fund is generally included in 2-6 deals every year. The high activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of UCB Ventures:
Typical Co-investors
UCB Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after UCB Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Belgium
Funds with similar focus located in Belgium:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Barings Equity Partners China, Hong Kong, Hong Kong Island
Bpmpartners Connecticut, Stamford, United States
Chunxiao Capital Beijing, Beijing, China
Custodi di successo Italy, Veneto, Vicenza
EIG Global Energy Partners(EIG) District of Columbia, United States, Washington
GAC Capital Anhui, China, Yuexi
HBAN Medtech Syndicate -
International Coach Federation Kentucky, Lexington, United States
Oddo & Cie Switzerland, Zürich, Zurich
Republic New York, New York, United States
Sequoia Scout -
The ALS Association District of Columbia, United States, Washington
Tohoku University Venture Partners Japan, Miyagi Prefecture, Sendai
VEF Stockholm, Stockholm County, Sweden
Woofoo Capital -
Xijie Touzi China, Shanghai
Yuan Capital China, Hong Kong, Hong Kong Island

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Code Biotherapeutics

Life Science
$75M07 Jun 2022 Hatfield, Pennsylvania, United States

Splice Bio

Life Science
$59M15 Feb 2022 Barcelona, Catalonia, Spain

Neurona Therapeutics

Health Care
$41M22 Jun 2021 San Francisco, California, United States

Rinri Therapeutics

$11M20 Apr 2021 Massachusetts, United States


Health Care
Information Technology
$81M16 Mar 2021 Durham, North Carolina, United States

Health Care
$100M14 Dec 2020 San Diego, California, United States

Life Science
$51M06 Oct 2020 Cambridge, Massachusetts, United States

Syndesi Therapeutics

Health Care
$7M28 Sep 2020 Belgium, Limburg, Belgium

ExeVir Bio

Health Care
Life Science
$49M28 Jul 2020 Ghent, East Flanders, Belgium
ExeVir Closes US$50M Series A Financing

– ExeVir from Ghent, Belgium develops single domain antibody therapies providing broad protection against viral infections.
– The company closed its Series A financing raising a total of US$50m.
– Led by Fund+, the round was also joined by VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures and new investors SRIW, Noshaq, Vives IUF, SambrInvest as well as several Belgian family offices.
– The company is using the funds to commence the global phase 1b/2 clinical trial of lead compound XVR011 and develop a VHH72-Fc sub-cutaneous formulation for Covid-19 in parallel and accelerate development of its pipeline beyond Covid-19 in infectious diseases.

StrideBio Closes $81.5M Series B Financing

– StrideBio, Inc. is a Research Triangle Park, N.C.-based developer of novel engineered adeno-associated virus (AAV) based gene therapies.
– The company closed a $81.5m Series B funding round.
Northpond Ventures and Novo Holdings A/S co-led the round with new investors Pontifax, Octagon Capital, Sarepta Therapeutics, CaaS Capital and UF Innovate Ventures joining existing investors Hatteras Venture Partners, UCB Ventures, Takeda Ventures and Alexandria Venture Investments.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent UCB Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: